logo
Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?

Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?

Milestone Pharmaceuticals (MIST) stock sank on Friday after the biopharmaceutical company announced plans for a proposed public offering. The company said this offering will include shares of its common stock, coupled with Series A and Series B warrants that holders will be able to exercise for additional shares.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Milestone Pharmaceuticals hasn't nailed down the specifics of the public offering. That means traders don't know how many shares and warrants it will include, or what they will be priced at. Even so, news of a public offering weighed on the shares, as it will likely be priced below the stock's current value, and newly issued shares will dilute the stakes of current investors.
Milestone Pharmaceuticals noted that the funds gained from the public offering will be used to continue its clinical development and commercial launch of etripamil, as working capital, and for other general corporate purposes.
Milestone Pharmaceuticals Stock Movement Today
Milestone Pharmaceuticals stock was down 32.03% during pre-market trading on Friday, following a 6.67% rally yesterday. The stock has risen 8.47% year-to-date and 64.1% over the past 12 months. Today's news triggered a sell-off of MIST shares, with over 1.2 million units traded, compared to a three-month daily average of about 688,000 shares.
Is Milestone Pharmaceuticals Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts' consensus rating for Milestone Pharmaceuticals is Moderate Buy, based on one Buy and one Hold rating over the past three months. With that comes an average MIST stock price target of $5, representing a potential 96.31% upside for the shares.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Monday.com price target lowered to $270 from $350 at Goldman Sachs
Monday.com price target lowered to $270 from $350 at Goldman Sachs

Business Insider

time40 minutes ago

  • Business Insider

Monday.com price target lowered to $270 from $350 at Goldman Sachs

Goldman Sachs lowered the firm's price target on (MNDY) to $270 from $350 and keeps a Buy rating on the shares. The stock fell 30% after earnings as investors react to contracting customer adds, material step downs in new product net adds, and small business headwinds, the analyst tells investors in a research note. For a growth company, a negative inflection in the channel, sourcing leads, and new product momentum could have outsized impacts to both short-term and long-term growth potential, the firm adds. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

SmartCentres Real Estate Investment Trust (SRU.UN) Receives a Hold from Scotiabank
SmartCentres Real Estate Investment Trust (SRU.UN) Receives a Hold from Scotiabank

Business Insider

timean hour ago

  • Business Insider

SmartCentres Real Estate Investment Trust (SRU.UN) Receives a Hold from Scotiabank

Scotiabank analyst maintained a Hold rating on SmartCentres Real Estate Investment Trust today and set a price target of C$27.50. The company's shares closed today at C$25.97. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. In addition to Scotiabank, SmartCentres Real Estate Investment Trust also received a Hold from BMO Capital's Michael Markidis in a report issued yesterday. However, today, TR | OpenAI – 4o reiterated a Buy rating on SmartCentres Real Estate Investment Trust (TSX: The company has a one-year high of C$27.50 and a one-year low of C$23.18. Currently, SmartCentres Real Estate Investment Trust has an average volume of 277.8K.

National Bank Sticks to Its Buy Rating for Rogers Communication (RCI)
National Bank Sticks to Its Buy Rating for Rogers Communication (RCI)

Business Insider

timean hour ago

  • Business Insider

National Bank Sticks to Its Buy Rating for Rogers Communication (RCI)

National Bank analyst Adam Shine maintained a Buy rating on Rogers Communication today and set a price target of C$59.00. The company's shares closed today at $34.14. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Shine is a 3-star analyst with an average return of 3.3% and a 50.19% success rate. Shine covers the Communication Services sector, focusing on stocks such as BCE, Rogers Communication, and Telus. In addition to National Bank, Rogers Communication also received a Buy from TR | OpenAI – 4o's Dialyn Tone in a report issued yesterday. However, today, Barclays maintained a Hold rating on Rogers Communication (NYSE: RCI).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store